Associated Papers
Understanding the co-evolutionary molecular mechanisms of resistance in the HIV-1 Gag and protease.
Marie V et al.
Journal of Biomolecular Structure & Dynamics, 2022
The influence of protease inhibitor resistance profiles on selection of HIV therapy in treatment-naive patients.
Turner D et al.
Antiviral Therapy, 2004
Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors.
Gatanaga H et al.
The Journal of Biological Chemistry, 2002
Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors.
Croteau G et al.
Journal of Virology, 1997
Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants.
Pazhanisamy S et al.
The Journal of Biological Chemistry, 1996
Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors.
Doyon L et al.
Journal of Virology, 1996
Design, synthesis, and resistance patterns of MP-134 and MP-167, two novel inhibitors of HIV type 1 protease.
Mo H et al.
Aids Research and Human Retroviruses, 1996
Select a paper to view details